Manager of Regulatory Affairs, EMEA, Thermo Fisher Scientific
BIOGRAPHY
In this webinar, you’ll learn about the value of the new in vitro diagnostic regulation (IVDR) and its impact on molecular pathology laboratories, biotechnology and pharma industries, as well as its benefit to the future of precision medicine.
Learning objectives:
• Explain the differences between in vitro diagnostic directive (IVDD) and IVDR, and the benefits of the new regulation
• Identify the IVDR challenges and bottlenecks that industries are facing and ways to mitigate them
• Discuss the IVDR impact on laboratory-developed tests (LDTs) and implications for molecular pathology laboratories and patients